Cargando…

β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) less often receive β-blockers after acute myocardial infarction (AMI). This may influence their outcomes after AMI. This study evaluated the efficacy of β-blockers after AMI in patients with COPD, compared with non-dihydropyridin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Tse-Hsuan, Chang, Shang-Hung, Kuo, Chang-Fu, Liu, Pi-Hua, Chan, Yi-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400336/ https://www.ncbi.nlm.nih.gov/pubmed/30835781 http://dx.doi.org/10.1371/journal.pone.0213187

Ejemplares similares

Temporal Trends in Treatment and Outcomes of Acute Myocardial Infarction in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Population‐Based Observational Study
por: Su, Tse‐Hsuan, et al.
Publicado: (2017)

Selection of β‐Blocker in Patients With Cirrhosis and Acute Myocardial Infarction: A 13‐Year Nationwide Population‐Based Study in Asia
por: Wu, Victor Chien‐Chia, et al.
Publicado: (2018)

β‐Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study
por: Andell, Pontus, et al.
Publicado: (2015)

Familial aggregation of myocardial infarction and coaggregation of myocardial infarction and autoimmune disease: a nationwide population-based cross-sectional study in Taiwan
por: Wang, Chun-Li, et al.
Publicado: (2019)

Long-Term Effect of Non-Selective Beta-Blockers in Patients With Rheumatoid Arthritis After Myocardial Infarction—A Nationwide Cohort Study
por: Liu, Sheng-Fu, et al.
Publicado: (2021)

Class effect of beta-blockers in survivors of ST-elevation myocardial infarction: A nationwide cohort study using an insurance claims database
por: Lin, Ting-Tse, et al.
Publicado: (2015)

Long-term efficacy of vasodilating β-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry
por: Chung, Jaehoon, et al.
Publicado: (2021)

Effect of β‐Blockers Beyond 3 Years After Acute Myocardial Infarction
por: Park, Jin Joo, et al.
Publicado: (2018)

Benefit of Vasodilating β‐Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study
por: Chung, Jaehoon, et al.
Publicado: (2017)

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
por: Lipworth, Brian, et al.
Publicado: (2016)

Due caution using early β-blockers for acute myocardial infarction
por: McKee, Scott, et al.
Publicado: (2007)

Nationwide cohort study of outcomes of acute myocardial infarction in patients with liver cirrhosis: A nationwide cohort study
por: Wu, Victor Chien-Chia, et al.
Publicado: (2020)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Effect of β-Blockers on the Risk of Atrial Fibrillation in Patients with Acute Myocardial Infarction
por: Pesaro, Antonio Eduardo, et al.
Publicado: (2010)

β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease – A Danish Nationwide Study of 1·3 Million Individuals
por: Nielsen, Anne Orholm, et al.
Publicado: (2019)

The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study
por: Wang, Mei-Tzu, et al.
Publicado: (2018)

Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis—A nationwide cohort study
por: Lin, Ting-Tse, et al.
Publicado: (2017)

Chronic Obstructive Pulmonary Disease Increases the Risk of Mortality among Patients with Colorectal Cancer: A Nationwide Population-Based Retrospective Cohort Study
por: Cheng, Wei-Jen, et al.
Publicado: (2021)

Increase use of β-blockers in patients with chronic obstructive pulmonary and cardiovascular disease
por: Yang, Yan-Li, et al.
Publicado: (2021)

Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction – A 13-year nationwide cohort study
por: Wu, Victor Chien-Chia, et al.
Publicado: (2019)

Risk of Acute Myocardial Infarction in Patients with Gastroenteritis: A Nationwide Case-Control Study
por: Tai, Ying-Hsuan, et al.
Publicado: (2022)

β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature
por: DiNicolantonio, James J, et al.
Publicado: (2015)

β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study
por: Hagsund, Tora, et al.
Publicado: (2020)

β‐Blocker Therapy After Myocardial Infarction: A Little Goes a Long Way
por: Abbott, J. Dawn, et al.
Publicado: (2023)

Association of acute myocardial infarction with influenza: A nationwide observational study
por: Mohammad, Moman A., et al.
Publicado: (2020)

Incidence of intoxication events and patient outcomes in Taiwan: A nationwide population-based observational study
por: Chen, Chun-Kuei, et al.
Publicado: (2020)

Chronic obstructive pulmonary disease and β‐blocker treatment in Asian patients with heart failure
por: Kubota, Yoshiaki, et al.
Publicado: (2017)

Different Non-selective β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2019)

Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease
por: Verdecchia, Paolo, et al.
Publicado: (2021)

The double jeopardy of chronic obstructive pulmonary disease and myocardial infarction
por: Sinha, Shashank S, et al.
Publicado: (2014)

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction
por: Dondo, Tatendashe B., et al.
Publicado: (2017)

Contribution of Hepatitis B to Long-Term Outcome Among Patients With Acute Myocardial Infarction: A Nationwide Study
por: Kuo, Pei-Lun, et al.
Publicado: (2016)

Outcomes of patients with hypertrophic cardiomyopathy and acute myocardial infarction: a propensity score-matched, 15-year nationwide population-based study in Asia
por: Wu, Victor Chien-Chia, et al.
Publicado: (2018)

Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study
por: Short, Philip M, et al.
Publicado: (2011)

Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study
por: Dong, Yaa-Hui, et al.
Publicado: (2017)

Relapse of chronic obstructive pulmonary disease and myocardial infarction: what is the connection?
por: Terrosu, Pierfranco
Publicado: (2020)

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study
por: Puymirat, Etienne, et al.
Publicado: (2016)

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study
Publicado: (2016)

Long‐term impact of β‐blocker in elderly patients without myocardial infarction after percutaneous coronary intervention
por: Fukase, Tatsuya, et al.
Publicado: (2021)

Sustained beneficial effect of β-blockers on clinical outcomes after discontinuation in patients with ST elevation myocardial infarction
por: Park, Jin-Sun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3tlipunmtbrn3sbqaitsvebnd5